Non-Invasive aortic wave intensity analysis

  • Research type

    Research Study

  • Full title

    Non-Invasive aortic wave intensity analysis

  • IRAS ID

    232836

  • Contact name

    Michael Henein

  • Contact email

    michael.henein@ldh.nhs.uk

  • Sponsor organisation

    Luton and Dunstable University Hospital NHS Foundation Trust

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    This study aims at validating a non-invasive technique for the determination of local pulse wave velocity (PWV) and the use of wave intensity analysis (WIA) as a tool for describing the cardio-vascular interaction. These parameters are used as direct surrogates for aortic stiffness, hardening, distensibility and ventricular load in assessing patient’s health.

    Arterial stiffness (hardening) is an independent risk factor for cardiovascular related death. Current available techniques used for determining PWV, measure an average value between two locations (foot-to-foot technique) and are not able to account for changes is mechanical or geometrical properties of the arteries.

    More recent techniques are based on invasive measurements of pressure and velocity. These measurements determine the local PWV and estimate arterial mechanical properties (stiffness, distensibility and compliance) as well as cardio-vascular interaction (left ventricular load).

    To avoid these drawbacks, the technique proposed in this study aims at measuring direct, local and non-invasive PWV in the ascending aorta. The parameters assessed by echocardiographic measurements are vessel diameter (D) and flow velocity (U), which, based on the technique described are used to determine PWV.

    Wave intensity analysis (WIA) is used for studying the cardio-arterial interaction. In particular, it is used to provide information about the time and energy carried by the reflected waves, which are of clinical interest.

    The patients aimed to be studied for establishing aortic stiffness and ventricular load in the ascending aorta are healthy individuals and those with treated hypertension.

  • REC name

    East of England - Cambridge East Research Ethics Committee

  • REC reference

    18/EE/0379

  • Date of REC Opinion

    6 Nov 2018

  • REC opinion

    Unfavourable Opinion